QA: Balchem CORP in us_medicinal_products/2025

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000009326_2026_Balchem_CORP.pdf

Logs

info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0000009326, Balchem CORP

  xvar xval
0 LiabilitiesNoncurrent 11,324,000
1 LiabilitiesCurrent 230,527,000
2 remainder_Liabilities 186,988,000
3 AssetsCurrent 365,614,000
4 AssetsNoncurrent 32,806,000
5 PropertyPlantAndEquipmentNet 306,648,000
6 Goodwill 949,369,000
7 remainder_Assets 31,815,000
8 GeneralAndAdministrativeExpense 809,325,000
9 ResearchAndDevelopmentExpense 18,510,000
10 remainder_Expenses 44,185,000
11 remainder_Revenues 1,037,161,000
12 remainder_NetIncome -10,296,000
13 remainder_ComprehensiveNetIncome 65,294,000
  yvar yval
0 Liabilities 428,839,000
1 Assets 1,686,252,000
2 Expenses 872,020,000
3 Revenues 1,037,161,000
4 StockholdersEquity 1,257,413,000
5 NetIncome 154,845,000
6 ComprehensiveNetIncome 187,492,000
7 BaseVar 2,049,931,000
8 EconomicCapitalRatiobeforeLimitedLiability 1.81
9 EconomicCapitalRatio 2.22

Edgar->Model Mapping

Feature Distribution

Change over Time